Condition
Premature Baby 33 to 36 Weeks
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Not Yet Recruiting3
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07261046Not ApplicableNot Yet Recruiting
Comparison of Two Early Treatments for Premature Babies and Their Effects Over Time
NCT06348641Not ApplicableNot Yet Recruiting
Reducing Pain and Increasing Comfort During a Retinopathy of Prematurity Examination
NCT06306794Not ApplicableNot Yet Recruiting
Reducing Pain Levels and Increasing Comfort of Premature Infants During Aspiration
NCT06287710Recruiting
Fluid Responsiveness Evaluation by a Non-invasive Method in Children, Extended to PREterm Infants - FRENCH-PREMA
NCT04368767Not ApplicableCompletedPrimary
A Pilot Randomized Controlled Trial of the Effects of Daily Skin-to-skin Contact (PRCTS2S)
Showing all 5 trials